#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2978	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2512	343.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1951	1951	T	460	T,C	403,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2978	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2512	343.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1685	1685	C	430	C	365	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4097	314.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1957	1957	A	342	A,T	288,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4097	314.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2591	2591	C	386	C,A	332,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4097	314.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2665	2665	A	404	A	346	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4314	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4097	314.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3217	3217	C	383	C,T	323,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	500	folP	855	855	100.0	folP.l15.c4.ctg.1	1828	81.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1166	1168	AGC	106;105;103	A;G;C	93;93;90	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1136	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3839	88.6	1	SNP	p	S91F	1	.	.	271	273	TTC	797	799	TTC	84;84;85	T;T,C;C	74;72,1;76	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1136	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3839	88.6	1	SNP	p	D95G	1	.	.	283	285	GGC	809	811	GGC	85;85;86	G;G;C	75;73;74	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1136	gyrA	2751	2751	99.96	gyrA.l6.c4.ctg.1	3839	88.6	1	SNP	p	G95N	0	.	.	283	285	GGC	809	811	GGC	85;85;86	G;G;C	75;73;74	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	454	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1637	82.8	1	SNP	p	G45D	0	.	.	133	135	GGC	676	678	GGC	133;135;135	G,T;G;C	111,1;117;114	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	310	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1234	74.8	0	.	n	.	0	A197.	DEL	197	197	A	719	719	A	130	A	116	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1439	1441	GTC	123;123;124	G;T;C	102;99;103	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	1	SNP	p	D86N	0	.	.	256	258	GAC	545	547	GAC	122;124;124	G;A,G,C;C	102;99,1,1;103	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	1	SNP	p	S87R	1	.	.	259	261	CGT	548	550	CGT	124;122;122	C;G;T	103;103;98	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	1	SNP	p	R87I	0	.	.	259	261	CGT	548	550	CGT	124;122;122	C;G;T	103;103;98	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	1	SNP	p	R87W	0	.	.	259	261	CGT	548	550	CGT	124;122;122	C;G;T	103;103;98	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1064	parC	2304	2304	99.87	parC.l6.c17.ctg.1	3008	105.0	1	SNP	p	S88P	0	.	.	262	264	TCC	551	553	TCC	122;122;122	T;C,T;C	97;100,1;100	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	882	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3013	87.5	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1549	1551	TGC	125;126;126	T;G;C	102;100;103	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	882	parE	1986	1986	99.95	parE.l6.c4.ctg.1	3013	87.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1759	1761	GGC	111;111;112	G;G;C	94;96;101	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1540	1542	GCA	122;122;122	G;C,A;A	105;106,1;109	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1543	1545	ATC	123;123;123	A;T;C	105;104;104	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1555	1557	GTG	122;123;124	G;T,A;G	108;107,1;106	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1555	1557	GTG	122;123;124	G;T,A;G	108;107,1;106	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2059	2061	ACC	88;88;87	A;C;C	75;73;74	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2113	2115	GCG	92;90;89	G;C;G	77;71;70	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2113	2115	GCG	92;90;89	G;C;G	77;71;70	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2236	2238	GGC	104;103;103	G,C;G,T;C	87,1;88,1;87	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2245	2247	GGC	104;104;104	G;G;C	87;82;86	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	782	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2840	82.6	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2263	2265	TCG	105;106;107	T,G;C;G	88,1;92;92	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	956	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3562	80.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1891	1893	CCG	95;95;97	C;C;G,T	79;82;76,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	554	porA	1146	1146	99.56	porA.l6.c17.ctg.1	2282	72.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	834	834	C	96	C	78	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	626	628	GAA	106;107;107	G,A;A;A	91,1;93;92	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	914	916	GAT	115;115;115	G;A;T,G	94;95;91,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1037	1039	TCA	111;111;108	T,A;C;A	91,1;94;90	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1166	1168	GTC	117;115;117	GT,G;T;C,A	96,1;97;98,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1388	1390	ACT	124;125;124	A;C;T	100;102;103	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1496	1498	GCA	109;110;110	G;C;A,C	97;98;96,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	1	SNP	p	G120K	1	.	.	358	360	AAG	872	874	AAG	118;118;117	A,G;A,G;G,T,C	99,1;96,2;96,1,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	1	SNP	p	A121D	1	.	.	361	363	GAC	875	877	GAC	117;115;115	G,A;A,G,C;C	99,1;97,1,1;97	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	560	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	2037	81.8	1	SNP	p	D121N	0	.	.	361	363	GAC	875	877	GAC	117;115;115	G,A;A,G,C;C	99,1;97,1,1;97	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1912	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5370	106.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2304	2306	AAT	105;105;105	A;A;T	92;91;91	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	274	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1424	57.7	1	SNP	p	V57M	1	.	.	169	171	ATG	714	716	ATG	111;111;111	A;T;G	93;96;97	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1067	1069	ACG	35;35;36	A;C;G	33;33;32	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1088	1090	GAC	36;35;35	G;A;C	31;30;28	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1106	1108	ATG	37;37;37	A;T;G	31;31;30	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1118	1120	TCA	38;38;37	T;C;A	29;28;30	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1274	1276	CCG	45;44;43	C;C;G	37;35;37	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	K252N	NONSYN	754	756	AAA	1292	1294	AAT	43;42;42	A;A;T	36;36;35	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	S259T	NONSYN	775	777	TCG	1313	1315	ACA	40;40;41	A;C;A	36;36;36	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	E260K	NONSYN	778	780	GAA	1316	1318	AAA	41;41;41	A;A;A	36;35;36	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1376	1378	TCG	38;38;37	T;C;G	31;32;31	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	I283V	NONSYN	847	849	ATA	1385	1387	GTA	36;37;37	G;T;A	29;30;30	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	I291V	NONSYN	871	873	ATT	1409	1411	GTT	36;36;36	G;T;T	29;31;31	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	K307R	NONSYN	919	921	AAG	1457	1459	AGA	34;34;34	A;G;A	31;30;31	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1547	1549	AAA	31;31;30	A;A;A	29;30;29	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1550	1552	AAG	30;30;30	A;A;G	28;28;28	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1565	1567	CAC	30;30;30	C;A;C	28;29;27	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1604	1606	GAA	32;33;33	G;A;A	29;30;31	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1682	1684	ACG	37;37;37	A;C;G	29;30;29	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1733	1735	ATT	28;28;28	A,T;T;T	21,1;22;23	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1736	1738	AGT	28;28;28	A;G;T	22;23;23	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1775	1777	CTA	36;36;38	C;T;A	27;28;29	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1817	1819	AAT	36;37;37	A,G;A;T	31,1;31;31	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1886	1888	TCA	40;40;40	T;C;A	35;33;34	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1910	1912	ATG	35;35;36	A;T;G	31;32;32	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	416	tetM	1920	1920	95.62	tetM.l15.c4.ctg.1	3037	41.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2300	2302	GAA	48;48;48	G;A;A	43;41;44	.	Tetracycline resistance
